Cargando…

Outcomes of patients with stage III non-small cell lung cancer (NSCLC) that harbor a STK11 mutation

BACKGROUND: STK11 mutation (STK11(m)) in patients (pts) with stage IV non-small cell lung cancer (NSCLC) is associated with inferior survival and poor response to immune checkpoint inhibitors (ICI). The significance of STK11(m) in stage III NSCLC pts treated with concurrent chemoradiation (CCRT) wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	An, Josiah, Yan, Melissa, Yu, Nanmeng, Chennamadhavuni, Adithya, Furqan, Muhammad, Mott, Sarah L., Loeffler, Bradley T., Kruser, Timothy, Sita, Timothy L., Feldman, Lawrence, Nguyen, Ryan, Pasquinelli, Mary, Hanna, Nasser H., Abu Hejleh, Taher
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435393/ https://www.ncbi.nlm.nih.gov/pubmed/34584860 http://dx.doi.org/10.21037/tlcr-21-177

Ejemplares similares

Activity of osimertinib in a patient with stage IV non-small cell lung cancer harboring HER2 exon 19, p.L755P mutation: case report
por: Jonsdottir, Gudbjorg, et al.
Publicado: (2023)

Patient Characteristics and Survival Outcomes of Non-Metastatic, Non-Clear Cell Renal Cell Carcinoma
por: An, Josiah, et al.
Publicado: (2022)

Narrative review: mesenchymal-epithelial transition inhibitors—meeting their target
por: Safi, Danish, et al.
Publicado: (2021)

The negative relationship between patients with NSCLC harbored STK11/KEAP1 copy number variation and immune microenvironment infiltration
por: Zhang, Chenyue
Publicado: (2021)

STK11 (LKB1) mutations in metastatic NSCLC: Prognostic value in the real world
por: Shire, Norah J., et al.
Publicado: (2020)

Characterization of the STK11 splicing variant as a normal splicing isomer in a patient with Peutz–Jeghers syndrome harboring genomic deletion of the STK11 gene
por: Masuda, Kenta, et al.
Publicado: (2016)

Exceptional durable response to everolimus in a patient with biphenotypic breast cancer harboring an STK11 variant
por: Parachoniak, Christine A., et al.
Publicado: (2017)

Circulating Tumor DNA in Identifying Resistant Sub-Clones Post EGFR Blockade: Implications for EGFR Rechallenge
por: Chennamadhavuni, Adithya, et al.
Publicado: (2022)

The Predictive Value of Peripheral Immune Cell Counts for the Presence of Brain Metastases in Stage IV Non-Small-Cell Lung Cancer (NSCLC)
por: Abuelbeh, I, et al.
Publicado: (2022)

Utilization and Outcomes of Surgical Castration in Comparison to Medical Castration in Metastatic Prostate Cancer
por: Garje, Rohan, et al.
Publicado: (2019)

Multivariable Analysis of 169 Cases of Advanced Cutaneous Melanoma to Evaluate Antibiotic Exposure as Predictor of Survival to Anti-PD-1 Based Immunotherapies
por: Swami, Umang, et al.
Publicado: (2020)

Therapeutic Potential of Combining PARP Inhibitor and Immunotherapy in Solid Tumors
por: Vikas, Praveen, et al.
Publicado: (2020)

Management of Oligoprogression in Patients with Metastatic NSCLC Harboring ALK Rearrangements
por: Pisano, Chiara, et al.
Publicado: (2022)

XPO1-mutant NSCLC without STK11/KEAP1 mutations may predict better survival to immunotherapy
por: Li, Xuanzong, et al.
Publicado: (2021)

STK system acceptance tests
por: Grau, X F
Publicado: (1997)

Optimal Treatments for NSCLC Patients Harboring Primary or Acquired MET Amplification
por: Sun, Dantong, et al.
Publicado: (2022)

Implications of pneumonitis after chemoradiation and durvalumab for locally advanced non-small cell lung cancer
por: Hassanzadeh, Comron, et al.
Publicado: (2020)

Changing incidence of esophageal cancer among white women: analysis of SEER data (1992–2010)
por: Raman, Rachna, et al.
Publicado: (2015)

Caenorhabditis elegans transposable elements harbor diverse transcription factor DNA-binding sites
por: Garrigues, Jacob M, et al.
Publicado: (2022)

Risk Factors and Biomarkers for Immune-Related Adverse Events: A Practical Guide to Identifying High-Risk Patients and Rechallenging Immune Checkpoint Inhibitors
por: Chennamadhavuni, Adithya, et al.
Publicado: (2022)

Hyperprogression on immunotherapy with complete response to chemotherapy in a NSCLC patient with high PD-L1 and STK11: A case report
por: Fricke, Jeremy, et al.
Publicado: (2020)

Systemic Therapy for Oligoprogression in Patients with Metastatic NSCLC Harboring Activating EGFR Mutations
por: Rossi, Antonio, et al.
Publicado: (2022)

Successful response to first-line treatment with osimertinib for choroidal metastasis from EGFR-mutated non-small-cell lung cancer
por: Field, Matthew G., et al.
Publicado: (2022)

Atezolizumab prolongs overall survival over docetaxel in advanced non-small-cell lung cancer patients harboring STK11 or KEAP1 mutation
por: Nie, Wei, et al.
Publicado: (2021)

Poly Adenosine Diphosphate-Ribose Polymerase (PARP) Inhibitors in Pancreatic Cancer
por: Sunkara, Tejasvi, et al.
Publicado: (2022)

Adjuvant EGFR TKIs in NSCLC harboring EGFR mutations: looking for a consensus way
por: Attili, Ilaria, et al.
Publicado: (2020)

Phase 1 Clinical Trial of Trametinib and Ponatinib in Patients With NSCLC Harboring KRAS Mutations
por: Arbour, Kathryn C., et al.
Publicado: (2021)

The Novel Small Molecule STK899704 Promotes Senescence of the Human A549 NSCLC Cells by Inducing DNA Damage Responses and Cell Cycle Arrest
por: Park, Chan-Woo, et al.
Publicado: (2018)

stk: A python toolkit for supramolecular assembly
por: Turcani, Lukas, et al.
Publicado: (2018)

Serine/Threonine Protein Kinase STK16
por: Wang, Junjun, et al.
Publicado: (2019)

SBRT to adrenal metastases provides high local control with minimal toxicity
por: Plichta, Kristin, et al.
Publicado: (2017)

Response to Afatinib in a Patient with NSCLC Harboring Novel EGFR Exon 20 Insertion Mutations
por: Lin, Ling, et al.
Publicado: (2020)

Favorable immune checkpoint inhibitor outcome of patients with melanoma and NSCLC harboring FAT1 mutations
por: Zhang, Wenjing, et al.
Publicado: (2022)

AXL targeting restores PD-1 blockade sensitivity of STK11/LKB1 mutant NSCLC through expansion of TCF1(+) CD8 T cells
por: Li, Huiyu, et al.
Publicado: (2022)

ZmSTK1 and ZmSTK2, encoding receptor‐like cytoplasmic kinase, are involved in maize pollen development with additive effect
por: Fan, Mingxia, et al.
Publicado: (2018)

Identification of the kinase STK25 as an upstream activator of LATS signaling
por: Lim, Sanghee, et al.
Publicado: (2019)

Association between diabetes mellitus and poor patient outcomes after out-of-hospital cardiac arrest: A systematic review and meta-analysis
por: Voruganti, Dinesh Chandra, et al.
Publicado: (2018)

Peutz-Jeghers syndrome with germline mutation of STK11
por: Chae, Hyun-Dong, et al.
Publicado: (2014)

Evidence That STK19 Is Not an NRAS-dependent Melanoma Driver
por: Rodríguez-Martínez, Marta, et al.
Publicado: (2020)

STK17B promotes the progression of ovarian cancer
por: Jiang, Liping, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f245lekdmd5s9dm1tlfifjhjga